Camfield P, Camfield C. Incidence, prevalence and aetiology of seizures and epilepsy in children. Epileptic Disord. 2015;17(2):117–23. https://doi.org/10.1684/epd.2015.0736.

Article  PubMed  Google Scholar 

Auvin S, Specchio N. Pharmacotherapeutic strategies for drug-resistant epilepsy in children. Epilepsy Behav. 2024;161: 110139. https://doi.org/10.1016/j.yebeh.2024.110139.

Article  PubMed  Google Scholar 

Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069–77. https://doi.org/10.1111/j.1528-1167.2009.02397.x.

Article  PubMed  CAS  Google Scholar 

Perucca E, Perucca P, White HS, Wirrell EC. Drug resistance in epilepsy. Lancet Neurol. 2023;22(8):723–34. https://doi.org/10.1016/S1474-4422(23)00151-5.

Article  PubMed  CAS  Google Scholar 

Perucca E, Brodie MJ, Kwan P, Tomson T. 30 years of second-generation antiseizure medications: impact and future perspectives. Lancet Neurol. 2020;19(6):544–56. https://doi.org/10.1016/S1474-4422(20)30035-1.

Article  PubMed  CAS  Google Scholar 

Rho JM, White HS. Brief history of anti-seizure drug development. Epilepsia Open. 2018;3(S2):114–9. https://doi.org/10.1002/epi4.12268.

Article  PubMed  PubMed Central  Google Scholar 

Perry MS. New and emerging medications for treatment of pediatric epilepsy. Pediatr Neurol. 2020;107:24–7. https://doi.org/10.1016/j.pediatrneurol.2019.11.008.

Article  PubMed  Google Scholar 

National Institute of Health and Care Excellence (NICE). NICE guideline [NG217]: epilepsies in children, young people and adults. 2022. https://www.nice.org.uk/guidance/ng217/chapter/5-Treating-epileptic-seizures-in-children-young-people-and-adults. Accessed 30 Jan 2025.

UK Medicines and Healthcare products Regulatory Agency (MHRA). New valproate safety measures apply from 31 January. 2024. https://www.gov.uk/government/news/new-valproate-safety-measures-apply-from-31-january#:~:text=From%20January%202024%2C%20valproate%20must,reproductive%20risks%20do%20not%20apply. Accessed 24 Mar 2025.

Tait L, Staniaszek LE, Galizia E, Martin-Lopez D, Walker MC, Azeez AAA, et al. Estimating the likelihood of epilepsy from clinically noncontributory electroencephalograms using computational analysis: a retrospective, multisite case-control study. Epilepsia. 2024;65(8):2459–69. https://doi.org/10.1111/epi.18024.

Article  PubMed  CAS  Google Scholar 

Shoeibi A, Khodatars M, Ghassemi N, Jafari M, Moridian P, Alizadehsani R, et al. Epileptic seizures detection using deep learning techniques: a review. Int J Environ Res Public Health. 2021;18(11):5780.

Article  PubMed  PubMed Central  Google Scholar 

Ripart M, Spitzer H, Williams LZJ, Walger L, Chen A, Napolitano A, et al. Detection of epileptogenic focal cortical dysplasia using graph neural networks: a MELD study. JAMA Neurol. 2025. https://doi.org/10.1001/jamaneurol.2024.5406.

Article  PubMed  Google Scholar 

Biondi A, Dursun E, Viana PF, Laiou P, Richardson MP. New wearable and portable EEG modalities in epilepsy: the views of hospital-based healthcare professionals. Epilepsy Behav. 2024;159: 109990. https://doi.org/10.1016/j.yebeh.2024.109990.

Article  PubMed  Google Scholar 

Sheidley BR, Malinowski J, Bergner AL, Bier L, Gloss DS, Mu W, et al. Genetic testing for the epilepsies: a systematic review. Epilepsia. 2022;63(2):375–87. https://doi.org/10.1111/epi.17141.

Article  PubMed  Google Scholar 

McKnight D, Morales A, Hatchell KE, Bristow SL, Bonkowsky JL, Perry MS, et al. Genetic testing to inform epilepsy treatment management from an international study of clinical practice. JAMA Neurol. 2022;79(12):1267–76. https://doi.org/10.1001/jamaneurol.2022.3651.

Article  PubMed  PubMed Central  Google Scholar 

Ko A, Jung DE, Kim SH, Kang H-C, Lee JS, Lee ST, et al. The efficacy of ketogenic diet for specific genetic mutation in developmental and epileptic encephalopathy. Front Neurol. 2018. https://doi.org/10.3389/fneur.2018.00530.

Article  PubMed  PubMed Central  Google Scholar 

Musto E, Gardella E, Møller RS. Recent advances in treatment of epilepsy-related sodium channelopathies. Eur J Paediatr Neurol. 2020;24:123–8. https://doi.org/10.1016/j.ejpn.2019.12.009.

Article  PubMed  Google Scholar 

Gjerulfsen CE, Oudin MJ, Furia F, Gverdtsiteli S, Landmark CJ, Trivisano M, et al. Cenobamate as add-on treatment for SCN8A developmental and epileptic encephalopathy. Epilepsia. 2025. https://doi.org/10.1111/epi.18257.

Article  PubMed  PubMed Central  Google Scholar 

Møller RS, Johannesen KM. Precision medicine: SCN8A encephalopathy treated with sodium channel blockers. Neurotherapeutics. 2016;13(1):190–1. https://doi.org/10.1007/s13311-015-0403-5.

Article  PubMed  Google Scholar 

Boerma RS, Braun KP, van de Broek MPH, van Berkestijn FMC, Swinkels ME, Hagebeuk EO, et al. Remarkable phenytoin sensitivity in 4 children with SCN8A-related epilepsy: a molecular neuropharmacological approach. Neurotherapeutics. 2016;13(1):192–7. https://doi.org/10.1007/s13311-015-0372-8.

Article  PubMed  CAS  Google Scholar 

Knowles JK, Helbig I, Metcalf CS, Lubbers Laura S, Isom LL, Demarest S, et al. Precision medicine for genetic epilepsy on the horizon: recent advances, present challenges, and suggestions for continued progress. Epilepsia. 2022;63(10):2461–75. https://doi.org/10.1111/epi.17332.

Article  PubMed  PubMed Central  Google Scholar 

Xu D, Chen S, Yang J, Wang X, Fang Z, Li M. Precision therapy with quinidine of KCNT1-related epileptic disorders: a systematic review. Br J Clin Pharmacol. 2022;88(12):5096–112. https://doi.org/10.1111/bcp.15479.

Article  PubMed  CAS  Google Scholar 

Bruno E, Simblett S, Lang A, Biondi A, Odoi C, Schulze-Bonhage A et al. Wearable technology in epilepsy: the views of patients, caregivers, and healthcare professionals. Epilepsy Behav. 2018;85:141–9. https://doi.org/10.1016/j.yebeh.2018.05.044.

Franco V, Perucca E. Pharmacological and therapeutic properties of cannabidiol for epilepsy. Drugs. 2019;79(13):1435–54. https://doi.org/10.1007/s40265-019-01171-4.

Article  PubMed  CAS  Google Scholar 

US Food and Drug Administration (FDA). Epidiolex (cannabidiol) prescribing information. 2018. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210365s021lbl.pdf. Accessed 25 Mar 2025.

Electronic medicines compendium (emc). Epidyolex (cannabidiol) summary of product characteristics (SmPC). 2021. https://www.medicines.org.uk/emc/product/10781/smpc. Accessed 25 Mar 2025.

Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, et al. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med. 2017;376(21):2011–20. https://doi.org/10.1056/NEJMoa1611618.

Article  PubMed  CAS  Google Scholar 

Devinsky O, Patel AD, Cross JH, Villanueva V, Wirrell EC, Privitera M, et al. Effect of cannabidiol on drop seizures in the Lennox–Gastaut syndrome. N Engl J Med. 2018;378(20):1888–97. https://doi.org/10.1056/NEJMoa1714631.

Article  PubMed  CAS  Google Scholar 

Thiele EA, Marsh ED, French JA, Mazurkiewicz-Beldzinska M, Benbadis SR, Joshi C, et al. Cannabidiol in patients with seizures associated with Lennox–Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2018;391(10125):1085–96. https://doi.org/10.1016/S0140-6736(18)30136-3.

Article  PubMed  CAS  Google Scholar 

Thiele EA, Bebin EM, Bhathal H, Jansen FE, Kotulska K, Lawson JA, et al. Add-on cannabidiol treatment for drug-resistant seizures in tuberous sclerosis complex: a placebo-controlled randomized clinical trial. JAMA Neurol. 2021;78(3):285–92. https://doi.org/10.1001/jamaneurol.2020.4607.

Article  PubMed  Google Scholar 

Bialer M, Perucca E. Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials. Epilepsia. 2020;61(6):1082–9. https://doi.org/10.1111/epi.16542.

Article  PubMed  CAS  Google Scholar 

Devinsky O, Thiele EA, Wright S, Checketts D, Morrison G, Dunayevich E, et al. Cannabidiol efficacy independent of clobazam: meta-analysis of four randomized controlled trials. Acta Neurol Scand. 2020;142(6):531–40. https://doi.org/10.1111/ane.13305.

Article  PubMed  PubMed Central  CAS